NCT01153893View on ClinicalTrials.gov

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

PHASE3CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

October 4, 2010

Primary Completion Date

February 16, 2011

Study Completion Date

February 16, 2011

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal vaccine GSK1024850A

Intramuscular injection, 1 or 2 doses

BIOLOGICAL

InfanrixTM

Intramuscular injection, 1dose

Trial Locations (1)

P.M.B. 21266

GSK Investigational Site, Ikeja / Lagos

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01153893 - Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria | Biotech Hunter | Biotech Hunter